In 2017, the first year of the Trump administration, the 10
largest drug companies spent a combined $ 74 million.
Not exact matches
But here's the problem for Valeant: According to its income statement, it
spends just 3 % of its revenue on R&D, compared to about 15 % to 20 % for
large drug companies.
Large companies (Big Pharma) spend considerable amounts on advertising and distribution, and often have large sales forces that promote their drugs to physicians to convince them to prescribe the
Large companies (Big Pharma)
spend considerable amounts on advertising and distribution, and often have
large sales forces that promote their drugs to physicians to convince them to prescribe the
large sales forces that promote their
drugs to physicians to convince them to prescribe the
drug.
Pfizer, the world's
largest drug company, and one that's proud of its scientific acumen, announced yesterday that it will cut R&D
spending in 2012 by about 20 %, from $ 8.5 billion to $ 7 billion.